Wyost Injection
Product Images NDC 61314-228

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Wyost (NDC 61314-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Wyost 01)

A line chart depicting changes in mean serum calcium levels over time in subjects treated with Denosumab 120 mg. The x-axis represents study days, ranging from baseline (BL) to day 57, with sample sizes below. The y-axes present corrected calcium measurements in mmol/L (left) and mg/dL (right), showing a decreasing trend with error bars for variability.*

FDA Label Image

Fb (Wyost 02)

WYOST 120 mg/1.7 mL (70 mg/mL) subcutaneous injection vial label. Contains denosumab as the active ingredient. Single-dose vial for subcutaneous use only. Sterile solution with no preservative. Manufactured by Sandoz Inc. NDC 61314-228-94.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.